Literature DB >> 6429402

DL-Serine: promoting activity on renal tumorigenesis by N-ethyl-N-hydroxyethylnitrosamine in rats.

Y Hiasa, N Enoki, Y Kitahori, N Konishi, T Shimoyama.   

Abstract

Subcutaneous injection of DL-serine increased the number and size of renal tubular cell tumors in male W rats treated with 500 or 1,000 ppm N-ethyl-N-hydroxyethylnitrosamine [(EHEN) CAS: 13147-25-6, 2-(ethylnitrosamino)ethanol]. At the end of the 32-week experiment, the incidences of renal tumors were 95% in rats treated with 1,000 ppm EHEN for 2 weeks and then given three sc injections of DL-serine every 2 weeks, 33% in rats treated with 1,000 ppm EHEN for 2 weeks, and 28% in rats treated with 500 ppm EHEN for 2 weeks and then given three sc injections of DL-serine every 2 weeks. No renal tumors were found in rats treated with 500 ppm EHEN alone or given three sc injections of DL-serine alone every 2 weeks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429402

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Possible application to medium-term organ bioassays for renal carcinogenesis modifiers in rats treated with N-ethyl-N-hydroxyethylnitrosamine and unilateral nephrectomy.

Authors:  Y Hiasa; N Konishi; S Nakaoka; M Nakamura; S Nishii; Y Kitahori; M Ohshima
Journal:  Jpn J Cancer Res       Date:  1991-12

2.  Promoting effects of potassium dibasic phosphate on early-stage renal carcinogenesis in unilaterally nephrectomized rats treated with N-ethyl-N-hydroxyethylnitrosamine.

Authors:  Y Hiasa; N Konishi; S Nakaoka; T Nakamura; K Nishii; M Ohshima
Journal:  Jpn J Cancer Res       Date:  1992-07

3.  Inhibitory effect of potassium citrate on rat renal tumors induced by N-ethyl-N-hydroxyethylnitrosamine followed by potassium dibasic phosphate.

Authors:  N Konishi; K Nishii; I Hayashi; S Nakaoka; K Matsumoto; T Yabuno; Y Kitahori; Y Hiasa
Journal:  Jpn J Cancer Res       Date:  1993-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.